MTOR and breast carcinoma: MicroRNA 99a overexpression has been shown to induce G1 cell-cycle arrest and apoptosis by lowering expression of the mammalian target of rapamycin (mTOR) gene, with miR-99a being a potential candidate for use as a therapeutic strategy for effectively controlling breast cancer development [139].